Bausch + Lomb (BLCO) Financials

$15.75 +0.04 (+0.25%)

Closing price 03:59 PM Eastern

Extended Trading

$15.62 -0.13 (-0.82%)

As of 04:11 PM Eastern

Annual Income Statements for Bausch + Lomb

This table shows Bausch + Lomb's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2020	2021	2022	2023	2024
Period end date	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	-18	182	6.00	-260	-317
Consolidated Net Income / (Loss)	-17	193	15	-248	-305
Net Income / (Loss) Continuing Operations	-17	193	15	-248	-305
Total Pre-Tax Income	290	318	73	-166	-234
Total Operating Income	260	329	207	130	162
Total Gross Profit	2,127	2,298	2,249	2,504	2,919
Total Revenue	3,412	3,765	3,768	4,146	4,791
Operating Revenue	3,412	3,765	3,768	4,146	4,791
Total Cost of Revenue	1,285	1,467	1,519	1,642	1,872
Operating Cost of Revenue	1,285	1,467	1,519	1,642	1,872
Total Operating Expenses	1,867	1,969	2,042	2,374	2,757
Selling, General & Admin Expense	1,253	1,389	1,478	1,736	2,082
Research & Development Expense	253	271	307	324	343
Amortization Expense	323	292	244	240	288
Other Operating Expenses / (Income)	38	17	13	74	44
Total Other Income / (Expense), net	30	-11	-134	-296	-396
Interest Expense	0.00	0.00	146	283	399
Interest & Investment Income	3.00	0.00	6.00	15	15
Other Income / (Expense), net	27	-11	6.00	-28	-12
Income Tax Expense	307	125	58	82	71
Net Income / (Loss) Attributable to Noncontrolling Interest	1.00	11	9.00	12	12
Basic Earnings per Share	($0.05)	$0.52	$0.02	($0.74)	($0.90)
Weighted Average Basic Shares Outstanding	350M	350M	350M	350.50M	351.80M
Diluted Earnings per Share	($0.05)	$0.52	$0.02	($0.74)	($0.90)
Weighted Average Diluted Shares Outstanding	350M	350M	350.20M	350.50M	351.80M
Weighted Average Basic & Diluted Shares Outstanding	-	-	350.00M	350.99M	352.47M

This table shows Bausch + Lomb's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025
Net Income / (Loss) Attributable to Common Shareholders	-18	-1.00	-90	-32	-84	-54	-167	-151	4.00	-3.00	-212
Consolidated Net Income / (Loss)	-15	-	-88	-29	-80	-51	-163	-148	8.00	-2.00	-211
Net Income / (Loss) Continuing Operations	-15	-	-88	-29	-80	-51	-163	-148	8.00	-2.00	-211
Total Pre-Tax Income	19	-2.00	-55	-19	-35	-57	-90	-76	-58	-10	-180
Total Operating Income	46	51	-2.00	43	40	49	6.00	26	43	87	-83
Total Gross Profit	570	576	559	618	615	712	675	733	732	779	655
Total Revenue	942	996	931	1,035	1,007	1,173	1,099	1,216	1,196	1,280	1,137
Operating Revenue	942	996	931	1,035	1,007	1,173	1,099	1,216	1,196	1,280	1,137
Total Cost of Revenue	372	420	372	417	392	461	424	483	464	501	482
Operating Cost of Revenue	372	420	372	417	392	461	424	483	464	501	482
Total Operating Expenses	524	525	561	575	575	663	669	707	689	692	738
Selling, General & Admin Expense	381	386	418	417	418	483	504	535	511	532	563
Research & Development Expense	77	78	77	85	82	80	82	84	84	93	86
Amortization Expense	59	56	57	56	47	80	74	74	72	68	67
Other Operating Expenses / (Income)	7.00	5.00	9.00	17	28	20	9.00	14	22	-1.00	22
Total Other Income / (Expense), net	-27	-53	-53	-62	-75	-106	-96	-102	-101	-97	-97
Interest Expense	35	47	50	58	76	99	99	102	100	98	94
Interest & Investment Income	2.00	3.00	3.00	5.00	4.00	3.00	3.00	3.00	4.00	5.00	3.00
Other Income / (Expense), net	6.00	-9.00	-6.00	-9.00	-3.00	-10	0.00	-3.00	-5.00	-4.00	-6.00
Income Tax Expense	34	-2.00	33	10	45	-6.00	73	72	-66	-8.00	31
Net Income / (Loss) Attributable to Noncontrolling Interest	3.00	1.00	2.00	3.00	4.00	3.00	4.00	3.00	4.00	1.00	1.00
Basic Earnings per Share	($0.05)	-	($0.26)	($0.09)	($0.24)	($0.15)	($0.48)	($0.43)	$0.01	-	($0.60)
Weighted Average Basic Shares Outstanding	350M	350M	350M	350.50M	350.80M	350.50M	351.10M	351.80M	351.90M	351.80M	352.80M
Diluted Earnings per Share	($0.05)	-	($0.26)	($0.09)	($0.24)	($0.15)	($0.48)	($0.43)	$0.01	-	($0.60)
Weighted Average Diluted Shares Outstanding	350M	350.20M	350M	350.50M	350.80M	350.50M	351.10M	351.80M	353.90M	351.80M	352.80M
Weighted Average Basic & Diluted Shares Outstanding	350.00M	350.00M	350.26M	350.70M	350.86M	350.99M	351.48M	351.90M	352.16M	352.47M	353.40M

This table details how cash moves in and out of Bausch + Lomb's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2020	2021	2022	2023	2024
Period end date	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Net Change in Cash & Equivalents	46	-61	203	-46	-18
Net Cash From Operating Activities	522	873	345	-17	232
Net Cash From Continuing Operating Activities	522	873	345	-17	232
Net Income / (Loss) Continuing Operations	-17	193	15	-248	-305
Consolidated Net Income / (Loss)	-17	193	15	-248	-305
Depreciation Expense	442	415	379	382	436
Amortization Expense	0.00	0.00	8.00	53	102
Non-Cash Adjustments To Reconcile Net Income	59	121	52	93	96
Changes in Operating Assets and Liabilities, net	38	144	-109	-297	-97
Net Cash From Investing Activities	-256	-214	-215	-2,109	-412
Net Cash From Continuing Investing Activities	-256	-214	-215	-2,109	-412
Purchase of Property, Plant & Equipment	-253	-193	-175	-181	-291
Purchase of Investments	-6.00	-35	-62	-1,958	-150
Divestitures	-	0.00	0.00	1.00	2.00
Sale and/or Maturity of Investments	9.00	14	22	29	27
Net Cash From Financing Activities	-232	-712	81	2,078	178
Net Cash From Continuing Financing Activities	-232	-712	81	2,078	178
Repayment of Debt	0.00	0.00	-16	-179	-431
Payment of Dividends	-7.00	-10	-11	-9.00	-10
Issuance of Debt	0.00	28	2,471	2,276	631
Other Financing Activities, net	-225	-730	-2,363	-10	-12
Effect of Exchange Rate Changes	12	-8.00	-8.00	2.00	-16

This table details how cash moves in and out of Bausch + Lomb's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025
Net Change in Cash & Equivalents	-149	83	-22	34	-32	-26	-9.00	-23	48	-34	-101
Net Cash From Operating Activities	27	159	-56	-24	48	15	41	15	154	22	-25
Net Cash From Continuing Operating Activities	27	159	-56	-24	48	15	41	15	154	22	-25
Net Income / (Loss) Continuing Operations	-15	-	-88	-29	-80	-51	-163	-148	8.00	-2.00	-211
Consolidated Net Income / (Loss)	-15	-	-88	-29	-80	-51	-163	-148	8.00	-2.00	-211
Depreciation Expense	93	93	91	93	82	116	110	110	110	106	106
Amortization Expense	3.00	3.00	3.00	3.00	19	28	25	25	26	26	27
Non-Cash Adjustments To Reconcile Net Income	29	26	27	26	17	23	14	18	18	46	35
Changes in Operating Assets and Liabilities, net	-83	37	-89	-117	10	-101	55	10	-8.00	-154	18
Net Cash From Investing Activities	-49	-90	-64	-28	-1,882	-135	-57	-74	-96	-185	-116
Net Cash From Continuing Investing Activities	-49	-90	-64	-28	-1,882	-135	-57	-74	-96	-185	-116
Purchase of Property, Plant & Equipment	-49	-50	-37	-27	-33	-84	-67	-72	-60	-92	-110
Purchase of Investments	-6.00	-42	-39	-6.00	-1,860	-53	-3.00	-4.00	-47	-96	-16
Divestitures	-	-	0.00	1.00	-	-	1.00	1.00	-	-	0.00
Sale and/or Maturity of Investments	6.00	2.00	12	4.00	11	2.00	12	1.00	11	3.00	10
Net Cash From Financing Activities	-109	-7.00	91	90	1,811	86	12	40	-20	146	31
Net Cash From Continuing Financing Activities	-109	-7.00	91	90	1,811	86	12	40	-20	146	31
Repayment of Debt	-6.00	-7.00	-6.00	-7.00	-157	-9.00	-58	-7.00	-9.00	-357	-10
Issuance of Debt	-	-	100	100	1,980	96	75	50	-	506	50
Other Financing Activities, net	-92	-	-3.00	-3.00	-3.00	-1.00	-5.00	-3.00	-1.00	-3.00	-9.00
Effect of Exchange Rate Changes	-18	21	7.00	-4.00	-9.00	8.00	-5.00	-4.00	10	-17	9.00

This table presents Bausch + Lomb's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2021	2022	2023	2024
Period end date	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Total Assets	10,823	11,144	13,442	13,469
Total Current Assets	1,635	2,137	2,742	2,788
Cash & Equivalents	174	354	331	305
Restricted Cash	3.00	26	3.00	11
Accounts Receivable	721	724	839	1,026
Inventories, net	572	628	1,028	1,036
Prepaid Expenses	165	405	541	410
Plant, Property, & Equipment, net	1,225	1,300	1,390	1,485
Total Noncurrent Assets	7,963	7,707	9,310	9,196
Goodwill	4,586	4,507	4,575	4,523
Intangible Assets	2,264	2,058	3,589	3,494
Noncurrent Deferred & Refundable Income Taxes	933	927	921	885
Other Noncurrent Operating Assets	180	215	225	294
Total Liabilities & Shareholders' Equity	10,823	11,144	13,442	13,469
Total Liabilities	1,421	4,043	6,522	6,925
Total Current Liabilities	1,099	1,296	1,579	1,738
Short-Term Debt	0.00	25	30	40
Accounts Payable	239	370	522	389
Accrued Expenses	860	901	1,027	1,309
Total Noncurrent Liabilities	322	2,747	4,943	5,187
Long-Term Debt	0.00	2,411	4,532	4,744
Noncurrent Deferred & Payable Income Tax Liabilities	24	7.00	14	13
Other Noncurrent Operating Liabilities	298	329	397	430
Commitments & Contingencies	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	9,402	7,101	6,920	6,544
Total Preferred & Common Equity	9,329	7,033	6,850	6,473
Total Common Equity	9,329	7,033	6,850	6,473
Common Stock	0.00	8,285	8,349	8,429
Retained Earnings	0.00	6.00	-254	-571
Accumulated Other Comprehensive Income / (Loss)	-1,035	-1,258	-1,245	-1,385
Noncontrolling Interest	73	68	70	71

This table presents Bausch + Lomb's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025
Period end date	9/30/2022	3/31/2023	6/30/2023	9/30/2023	3/31/2024	6/30/2024	9/30/2024	3/31/2025
Total Assets	10,696	11,169	11,315	13,068	13,293	13,250	13,515	13,428
Total Current Assets	1,859	2,184	2,315	2,464	2,743	2,769	2,828	2,694
Cash & Equivalents	287	346	384	355	315	285	329	202
Restricted Cash	10	12	8.00	5.00	10	17	21	13
Accounts Receivable	685	714	791	783	920	986	943	1,007
Inventories, net	605	697	699	754	1,073	1,069	1,119	1,031
Prepaid Expenses	272	415	433	567	425	412	416	441
Plant, Property, & Equipment, net	1,222	1,296	1,294	1,284	1,397	1,430	1,481	1,581
Total Noncurrent Assets	7,615	7,689	7,706	9,320	9,153	9,051	9,206	9,153
Goodwill	4,415	4,522	4,540	4,526	4,547	4,538	4,581	4,567
Intangible Assets	2,068	2,031	2,021	3,662	3,515	3,437	3,384	3,427
Noncurrent Deferred & Refundable Income Taxes	904	923	938	920	860	827	931	864
Other Noncurrent Operating Assets	228	213	207	212	231	249	310	295
Total Liabilities & Shareholders' Equity	10,696	11,169	11,315	13,068	13,293	13,250	13,515	13,428
Total Liabilities	3,901	4,117	4,285	6,185	6,564	6,670	6,854	6,995
Total Current Liabilities	1,199	1,254	1,325	1,386	1,617	1,676	1,801	1,726
Short-Term Debt	25	25	25	30	30	30	30	40
Accounts Payable	295	389	348	364	426	405	455	427
Accrued Expenses	879	840	952	992	1,161	1,241	1,316	1,259
Total Noncurrent Liabilities	2,702	2,863	2,960	4,799	4,947	4,994	5,053	5,269
Long-Term Debt	2,413	2,508	2,604	4,435	4,554	4,602	4,599	4,789
Noncurrent Deferred & Payable Income Tax Liabilities	10	14	14	11	14	14	12	13
Other Noncurrent Operating Liabilities	279	341	342	353	379	378	442	467
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	6,795	7,052	7,030	6,883	6,729	6,580	6,661	6,433
Total Preferred & Common Equity	6,729	6,983	6,958	6,817	6,659	6,504	6,589	6,361
Total Common Equity	6,729	6,983	6,958	6,817	6,659	6,504	6,589	6,361
Common Stock	8,108	8,305	8,321	8,334	8,363	8,382	8,405	8,448
Retained Earnings	7.00	-84	-116	-200	-421	-572	-568	-783
Accumulated Other Comprehensive Income / (Loss)	-1,386	-1,238	-1,247	-1,317	-1,283	-1,306	-1,248	-1,304
Noncontrolling Interest	66	69	72	66	70	76	72	72

This table displays calculated financial ratios and metrics derived from Bausch + Lomb's official financial filings.

Metric	2020	2021	2022	2023	2024
Period end date	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Growth Metrics	-	-	-	-	-
Revenue Growth	0.00%	10.35%	0.08%	10.03%	15.56%
EBITDA Growth	0.00%	0.55%	-18.14%	-10.50%	28.12%
EBIT Growth	0.00%	10.80%	-33.02%	-52.11%	47.06%
NOPAT Growth	0.00%	1,410.09%	-78.70%	113.95%	24.62%
Net Income Growth	0.00%	1,235.29%	-92.23%	-1,753.33%	-22.98%
EPS Growth	0.00%	1,140.00%	-96.15%	-3,800.00%	-21.62%
Operating Cash Flow Growth	0.00%	67.24%	-60.48%	-104.93%	1,464.71%
Free Cash Flow Firm Growth	0.00%	0.00%	101.22%	-1,818.92%	113.13%
Invested Capital Growth	0.00%	0.00%	-0.74%	21.74%	-1.22%
Revenue Q/Q Growth	0.00%	0.00%	-0.13%	4.46%	2.28%
EBITDA Q/Q Growth	0.00%	0.00%	-7.41%	9.15%	4.88%
EBIT Q/Q Growth	0.00%	0.00%	-17.12%	-2.86%	41.51%
NOPAT Q/Q Growth	0.00%	0.00%	-59.98%	-1.52%	30.65%
Net Income Q/Q Growth	0.00%	0.00%	-78.26%	-25.89%	13.84%
EPS Q/Q Growth	0.00%	0.00%	-87.50%	-25.42%	14.29%
Operating Cash Flow Q/Q Growth	0.00%	0.00%	-0.86%	-113.39%	3.11%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	3.04%	85.01%
Invested Capital Q/Q Growth	0.00%	0.00%	2.47%	1.46%	0.66%
Profitability Metrics	-	-	-	-	-
Gross Margin	62.34%	61.04%	59.69%	60.40%	60.93%
EBITDA Margin	21.37%	19.47%	15.92%	12.95%	14.36%
Operating Margin	7.62%	8.74%	5.49%	3.14%	3.38%
EBIT Margin	8.41%	8.45%	5.65%	2.46%	3.13%
Profit (Net Income) Margin	-0.50%	5.13%	0.40%	-5.98%	-6.37%
Tax Burden Percent	-5.86%	60.69%	20.55%	149.40%	130.34%
Interest Burden Percent	101.05%	100.00%	34.27%	-162.75%	-156.00%
Effective Tax Rate	105.86%	39.31%	79.45%	0.00%	0.00%
Return on Invested Capital (ROIC)	0.00%	4.33%	0.46%	0.90%	1.02%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	11.87%	-2.47%	-9.89%	-8.60%
Return on Net Nonoperating Assets (RNNOA)	0.00%	-0.22%	-0.28%	-4.43%	-5.55%
Return on Equity (ROE)	0.00%	4.11%	0.18%	-3.54%	-4.53%
Cash Return on Invested Capital (CROIC)	0.00%	-195.67%	1.20%	-18.71%	2.25%
Operating Return on Assets (OROA)	0.00%	2.94%	1.94%	0.83%	1.11%
Return on Assets (ROA)	0.00%	1.78%	0.14%	-2.02%	-2.27%
Return on Common Equity (ROCE)	0.00%	4.07%	0.18%	-3.50%	-4.48%
Return on Equity Simple (ROE_SIMPLE)	0.00%	2.07%	0.21%	-3.62%	-4.71%
Net Operating Profit after Tax (NOPAT)	-15	200	43	91	113
NOPAT Margin	-0.45%	5.30%	1.13%	2.19%	2.37%
Net Nonoperating Expense Percent (NNEP)	0.00%	-7.54%	2.93%	10.79%	9.62%
Return On Investment Capital (ROIC_SIMPLE)	-	-	0.45%	0.79%	1.00%
Cost of Revenue to Revenue	37.66%	38.96%	40.31%	39.60%	39.07%
SG&A Expenses to Revenue	36.72%	36.89%	39.23%	41.87%	43.46%
R&D to Revenue	7.42%	7.20%	8.15%	7.81%	7.16%
Operating Expenses to Revenue	54.72%	52.30%	54.19%	57.26%	57.55%
Earnings before Interest and Taxes (EBIT)	287	318	213	102	150
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	729	733	600	537	688
Valuation Ratios	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.07	0.77	0.87	0.98
Price to Tangible Book Value (P/TBV)	0.00	0.25	11.60	0.00	0.00
Price to Revenue (P/Rev)	0.18	0.17	1.44	1.44	1.33
Price to Earnings (P/E)	0.00	3.46	904.75	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	28.89%	0.11%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.06	0.82	0.92	0.99
Enterprise Value to Revenue (EV/Rev)	0.00	0.14	2.00	2.48	2.27
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.72	12.59	19.15	15.84
Enterprise Value to EBIT (EV/EBIT)	0.00	1.65	35.46	100.82	72.66
Enterprise Value to NOPAT (EV/NOPAT)	0.00	2.63	177.56	113.01	96.11
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.60	21.89	0.00	46.98
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	68.33	0.00	43.70
Leverage & Solvency	-	-	-	-	-
Debt to Equity	0.00	0.00	0.34	0.66	0.73
Long-Term Debt to Equity	0.00	0.00	0.34	0.65	0.72
Financial Leverage	0.00	-0.02	0.11	0.45	0.65
Leverage Ratio	0.00	1.15	1.33	1.75	2.00
Compound Leverage Factor	0.00	1.15	0.46	-2.85	-3.12
Debt to Total Capital	0.00%	0.00%	25.54%	39.73%	42.23%
Short-Term Debt to Total Capital	0.00%	0.00%	0.26%	0.26%	0.35%
Long-Term Debt to Total Capital	0.00%	0.00%	25.28%	39.47%	41.88%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.78%	0.71%	0.61%	0.63%
Common Equity to Total Capital	0.00%	99.22%	73.74%	59.66%	57.14%
Debt to EBITDA	0.00	0.00	4.06	8.50	6.95
Net Debt to EBITDA	0.00	0.00	3.43	7.87	6.49
Long-Term Debt to EBITDA	0.00	0.00	4.02	8.44	6.90
Debt to NOPAT	0.00	0.00	57.27	50.13	42.19
Net Debt to NOPAT	0.00	0.00	48.34	46.46	39.40
Long-Term Debt to NOPAT	0.00	0.00	56.68	49.80	41.83
Altman Z-Score	0.00	0.77	1.30	0.96	0.98
Noncontrolling Interest Sharing Ratio	0.00%	0.78%	0.85%	0.98%	1.05%
Liquidity Ratios	-	-	-	-	-
Current Ratio	0.00	1.49	1.65	1.74	1.60
Quick Ratio	0.00	0.81	0.83	0.74	0.77
Cash Flow Metrics	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	-9,025	111	-1,900	249
Operating Cash Flow to CapEx	206.32%	452.33%	197.14%	-9.39%	79.73%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.76	-6.71	0.63
Operating Cash Flow to Interest Expense	0.00	0.00	2.36	-0.06	0.58
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	1.16	-0.70	-0.15
Efficiency Ratios	-	-	-	-	-
Asset Turnover	0.00	0.35	0.34	0.34	0.36
Accounts Receivable Turnover	0.00	5.22	5.22	5.31	5.14
Inventory Turnover	0.00	2.56	2.53	1.98	1.81
Fixed Asset Turnover	0.00	3.07	2.98	3.08	3.33
Accounts Payable Turnover	0.00	6.14	4.99	3.68	4.11
Days Sales Outstanding (DSO)	0.00	69.90	69.99	68.80	71.04
Days Inventory Outstanding (DIO)	0.00	142.32	144.17	184.06	201.22
Days Payable Outstanding (DPO)	0.00	59.46	73.17	99.14	88.81
Cash Conversion Cycle (CCC)	0.00	152.75	140.99	153.72	183.45
Capital & Investment Metrics	-	-	-	-	-
Invested Capital	0.00	9,225	9,157	11,148	11,012
Invested Capital Turnover	0.00	0.82	0.41	0.41	0.43
Increase / (Decrease) in Invested Capital	0.00	9,225	-68	1,991	-136
Enterprise Value (EV)	0.00	526	7,553	10,284	10,899
Market Capitalization	630	630	5,429	5,986	6,360
Book Value per Share	$0.00	$26.65	$20.09	$19.52	$18.38
Tangible Book Value per Share	$0.00	$7.08	$1.34	($3.75)	($4.38)
Total Capital	0.00	9,402	9,537	11,482	11,328
Total Debt	0.00	0.00	2,436	4,562	4,784
Total Long-Term Debt	0.00	0.00	2,411	4,532	4,744
Net Debt	0.00	-177	2,056	4,228	4,468
Capital Expenditures (CapEx)	253	193	175	181	291
Debt-free, Cash-free Net Working Capital (DFCFNWC)	0.00	359	486	859	774
Debt-free Net Working Capital (DFNWC)	0.00	536	866	1,193	1,090
Net Working Capital (NWC)	0.00	536	841	1,163	1,050
Net Nonoperating Expense (NNE)	1.76	6.68	28	339	418
Net Nonoperating Obligations (NNO)	0.00	-177	2,056	4,228	4,468
Total Depreciation and Amortization (D&A)	442	415	387	435	538
Debt-free, Cash-free Net Working Capital to Revenue	0.00%	9.54%	12.90%	20.72%	16.16%
Debt-free Net Working Capital to Revenue	0.00%	14.24%	22.98%	28.77%	22.75%
Net Working Capital to Revenue	0.00%	14.24%	22.32%	28.05%	21.92%
Earnings Adjustments	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	$0.00	$0.02	($0.74)	($0.90)
Adjusted Weighted Average Basic Shares Outstanding	0.00	0.00	350M	350.50M	351.80M
Adjusted Diluted Earnings per Share	$0.00	$0.00	$0.02	($0.74)	($0.90)
Adjusted Weighted Average Diluted Shares Outstanding	0.00	0.00	350.20M	350.50M	351.80M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	0.00	350.00M	350.99M	352.47M
Normalized Net Operating Profit after Tax (NOPAT)	182	200	145	91	113
Normalized NOPAT Margin	5.33%	5.30%	3.85%	2.19%	2.37%
Pre Tax Income Margin	8.50%	8.45%	1.94%	-4.00%	-4.88%
Debt Service Ratios	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	1.46	0.36	0.38
NOPAT to Interest Expense	0.00	0.00	0.29	0.32	0.28
EBIT Less CapEx to Interest Expense	0.00	0.00	0.26	-0.28	-0.35
NOPAT Less CapEx to Interest Expense	0.00	0.00	-0.91	-0.32	-0.45
Payout Ratios	-	-	-	-	-
Dividend Payout Ratio	-41.18%	5.18%	73.33%	-3.63%	-3.28%
Augmented Payout Ratio	-41.18%	5.18%	73.33%	-3.63%	-3.28%

This table displays calculated financial ratios and metrics derived from Bausch + Lomb's official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-0.74%	-0.50%	4.72%	9.99%	6.90%	17.77%	18.05%	17.49%	18.77%	9.12%	3.46%
EBITDA Growth	-20.43%	-25.81%	-40.28%	-23.53%	-6.76%	32.61%	63.95%	21.54%	26.09%	17.49%	-68.79%
EBIT Growth	-40.91%	-51.16%	-116.33%	-51.43%	-28.85%	-7.14%	175.00%	-32.35%	2.70%	112.82%	-1,583.33%
NOPAT Growth	-153.96%	-38.20%	-103.27%	107.32%	177.10%	-3.92%	400.00%	-39.53%	7.50%	77.55%	-1,483.33%
Net Income Growth	-123.81%	0.00%	-482.61%	-514.29%	-433.33%	0.00%	-85.23%	-410.34%	110.00%	96.08%	-29.45%
EPS Growth	-129.41%	0.00%	-533.33%	-1,000.00%	-380.00%	0.00%	-84.62%	-377.78%	104.17%	0.00%	-25.00%
Operating Cash Flow Growth	-90.11%	-1.85%	-1,966.67%	-115.38%	77.78%	-90.57%	173.21%	162.50%	220.83%	46.67%	-160.98%
Free Cash Flow Firm Growth	0.00%	0.00%	100.19%	96.99%	77.44%	-1,986.89%	-10,081.82%	-502.00%	103.86%	110.06%	93.33%
Invested Capital Growth	0.00%	-0.74%	-0.21%	3.35%	22.96%	21.74%	19.09%	17.73%	-0.44%	-1.22%	0.54%
Revenue Q/Q Growth	0.11%	5.73%	-6.53%	11.17%	-2.71%	16.48%	-6.31%	10.65%	-1.64%	7.02%	-11.17%
EBITDA Q/Q Growth	-12.94%	-6.76%	-37.68%	51.16%	6.15%	32.61%	-22.95%	12.06%	10.13%	23.56%	-79.53%
EBIT Q/Q Growth	-25.71%	-19.23%	-119.05%	525.00%	8.82%	5.41%	-84.62%	283.33%	65.22%	118.42%	-207.23%
NOPAT Q/Q Growth	-350.13%	198.30%	-103.92%	2,250.00%	-6.98%	22.50%	-87.76%	333.33%	65.38%	102.33%	-195.40%
Net Income Q/Q Growth	-314.29%	0.00%	0.00%	67.05%	-175.86%	36.25%	-219.61%	9.20%	105.41%	-125.00%	-10,450.00%
EPS Q/Q Growth	-600.00%	0.00%	0.00%	65.38%	-166.67%	37.50%	-220.00%	10.42%	102.33%	0.00%	0.00%
Operating Cash Flow Q/Q Growth	-82.69%	488.89%	-135.22%	57.14%	300.00%	-68.75%	173.33%	-63.41%	926.67%	-85.71%	-213.64%
Free Cash Flow Firm Q/Q Growth	-0.22%	101.16%	-83.03%	-1,633.52%	-649.91%	3.33%	10.22%	7.51%	104.81%	152.11%	-159.47%
Invested Capital Q/Q Growth	-0.35%	2.47%	0.76%	0.43%	18.57%	1.46%	-1.44%	-0.71%	0.28%	0.66%	0.32%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	60.51%	57.83%	60.04%	59.71%	61.07%	60.70%	61.42%	60.28%	61.20%	60.86%	57.61%
EBITDA Margin	15.71%	13.86%	9.24%	12.56%	13.70%	15.60%	12.83%	12.99%	14.55%	16.80%	3.87%
Operating Margin	4.88%	5.12%	-0.21%	4.15%	3.97%	4.18%	0.55%	2.14%	3.60%	6.80%	-7.30%
EBIT Margin	5.52%	4.22%	-0.86%	3.29%	3.67%	3.32%	0.55%	1.89%	3.18%	6.48%	-7.83%
Profit (Net Income) Margin	-1.59%	0.00%	-9.45%	-2.80%	-7.94%	-4.35%	-14.83%	-12.17%	0.67%	-0.16%	-18.56%
Tax Burden Percent	-78.95%	0.00%	160.00%	152.63%	228.57%	89.47%	181.11%	194.74%	-13.79%	20.00%	117.22%
Interest Burden Percent	36.54%	-4.76%	687.50%	-55.88%	-94.59%	-146.15%	-1,500.00%	-330.43%	-152.63%	-12.05%	202.25%
Effective Tax Rate	178.95%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-3.26%	1.47%	-0.06%	1.25%	1.11%	1.19%	0.16%	0.67%	1.08%	2.06%	-2.24%
ROIC Less NNEP Spread (ROIC-NNEP)	-1.26%	-2.33%	-4.18%	-1.55%	-2.35%	-1.52%	-5.03%	-4.39%	0.55%	0.61%	-5.69%
Return on Net Nonoperating Assets (RNNOA)	-0.40%	-0.27%	-1.23%	-0.47%	-1.07%	-0.68%	-2.35%	-2.12%	0.34%	0.39%	-3.83%
Return on Equity (ROE)	-3.65%	1.20%	-1.29%	0.78%	0.03%	0.51%	-2.19%	-1.45%	1.41%	2.45%	-6.07%
Cash Return on Invested Capital (CROIC)	0.00%	1.20%	1.35%	-2.23%	-19.67%	-18.71%	-16.47%	-15.45%	1.23%	2.25%	-0.07%
Operating Return on Assets (OROA)	1.95%	1.45%	-0.30%	1.15%	1.23%	1.12%	0.19%	0.69%	1.12%	2.31%	-2.83%
Return on Assets (ROA)	-0.56%	0.00%	-3.26%	-0.98%	-2.65%	-1.47%	-5.23%	-4.45%	0.24%	-0.06%	-6.71%
Return on Common Equity (ROCE)	-3.62%	1.19%	-1.28%	0.77%	0.03%	0.51%	-2.17%	-1.44%	1.40%	2.43%	-6.01%
Return on Equity Simple (ROE_SIMPLE)	1.03%	0.00%	-1.37%	-1.90%	-2.89%	0.00%	-4.85%	-6.80%	-5.37%	0.00%	-5.55%
Net Operating Profit after Tax (NOPAT)	-36	36	-1.40	30	28	34	4.20	18	30	61	-58
NOPAT Margin	-3.86%	3.58%	-0.15%	2.91%	2.78%	2.92%	0.38%	1.50%	2.52%	4.76%	-5.11%
Net Nonoperating Expense Percent (NNEP)	-1.99%	3.80%	4.12%	2.79%	3.46%	2.71%	5.20%	5.06%	0.53%	1.45%	3.45%
Return On Investment Capital (ROIC_SIMPLE)	-	0.37%	-	-	-	0.30%	-	-	-	0.54%	-0.52%
Cost of Revenue to Revenue	39.49%	42.17%	39.96%	40.29%	38.93%	39.30%	38.58%	39.72%	38.80%	39.14%	42.39%
SG&A Expenses to Revenue	40.45%	38.76%	44.90%	40.29%	41.51%	41.18%	45.86%	44.00%	42.73%	41.56%	49.52%
R&D to Revenue	8.17%	7.83%	8.27%	8.21%	8.14%	6.82%	7.46%	6.91%	7.02%	7.27%	7.56%
Operating Expenses to Revenue	55.63%	52.71%	60.26%	55.56%	57.10%	56.52%	60.87%	58.14%	57.61%	54.06%	64.91%
Earnings before Interest and Taxes (EBIT)	52	42	-8.00	34	37	39	6.00	23	38	83	-89
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	148	138	86	130	138	183	141	158	174	215	44
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.80	0.77	0.87	1.01	0.87	0.87	0.91	0.78	1.03	0.98	0.80
Price to Tangible Book Value (P/TBV)	21.83	11.60	14.17	17.71	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	1.42	1.44	1.60	1.80	1.50	1.44	1.41	1.14	1.45	1.33	1.06
Price to Earnings (P/E)	92.57	904.75	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	1.08%	0.11%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.85	0.82	0.90	1.01	0.92	0.92	0.95	0.87	1.02	0.99	0.89
Enterprise Value to Revenue (EV/Rev)	2.01	2.00	2.19	2.39	2.55	2.48	2.41	2.12	2.38	2.27	2.03
Enterprise Value to EBITDA (EV/EBITDA)	11.69	12.59	15.38	18.60	20.56	19.15	17.57	15.34	16.98	15.84	16.58
Enterprise Value to EBIT (EV/EBIT)	29.48	35.46	53.45	77.82	96.34	100.82	89.64	90.57	105.09	72.66	178.12
Enterprise Value to NOPAT (EV/NOPAT)	71.28	177.56	78.88	96.67	109.47	113.01	107.65	112.27	128.33	96.11	191.72
Enterprise Value to Operating Cash Flow (EV/OCF)	21.77	21.89	29.15	88.10	79.65	0.00	129.99	79.91	49.51	46.98	59.02
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	68.33	66.86	0.00	0.00	0.00	0.00	0.00	82.63	43.70	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.36	0.34	0.36	0.37	0.65	0.66	0.68	0.70	0.69	0.73	0.75
Long-Term Debt to Equity	0.36	0.34	0.36	0.37	0.64	0.65	0.68	0.70	0.69	0.72	0.74
Financial Leverage	0.32	0.11	0.29	0.30	0.46	0.45	0.47	0.48	0.62	0.65	0.67
Leverage Ratio	1.57	1.33	1.55	1.59	1.74	1.75	1.78	1.80	1.96	2.00	2.03
Compound Leverage Factor	0.58	-0.06	10.64	-0.89	-1.64	-2.56	-26.63	-5.96	-3.00	-0.24	4.11
Debt to Total Capital	26.41%	25.54%	26.43%	27.22%	39.35%	39.73%	40.52%	41.31%	41.00%	42.23%	42.88%
Short-Term Debt to Total Capital	0.27%	0.26%	0.26%	0.26%	0.26%	0.26%	0.27%	0.27%	0.27%	0.35%	0.36%
Long-Term Debt to Total Capital	26.13%	25.28%	26.17%	26.96%	39.08%	39.47%	40.25%	41.05%	40.74%	41.88%	42.52%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.71%	0.71%	0.72%	0.75%	0.58%	0.61%	0.62%	0.68%	0.64%	0.63%	0.64%
Common Equity to Total Capital	72.88%	73.74%	72.85%	72.04%	60.07%	59.66%	58.86%	58.01%	58.36%	57.14%	56.48%
Debt to EBITDA	3.76	4.06	4.67	5.24	9.08	8.50	7.74	7.47	7.06	6.95	8.17
Net Debt to EBITDA	3.30	3.43	4.01	4.46	8.34	7.87	7.19	6.98	6.52	6.49	7.81
Long-Term Debt to EBITDA	3.72	4.02	4.63	5.19	9.01	8.44	7.69	7.42	7.01	6.90	8.10
Debt to NOPAT	22.94	57.27	23.96	27.22	48.32	50.13	47.45	54.69	53.33	42.19	94.50
Net Debt to NOPAT	20.14	48.34	20.58	23.16	44.43	46.46	44.09	51.12	49.30	39.40	90.29
Long-Term Debt to NOPAT	22.70	56.68	23.73	26.96	48.00	49.80	47.14	54.33	52.98	41.83	93.72
Altman Z-Score	1.27	1.25	1.32	1.43	0.97	0.95	0.94	0.84	0.98	0.96	0.78
Noncontrolling Interest Sharing Ratio	0.97%	0.85%	1.02%	1.05%	0.97%	0.98%	1.01%	1.09%	1.02%	1.05%	1.08%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.55	1.65	1.74	1.75	1.78	1.74	1.70	1.65	1.57	1.60	1.56
Quick Ratio	0.81	0.83	0.85	0.89	0.82	0.74	0.76	0.76	0.71	0.77	0.70
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-8,972	104	18	-270	-2,024	-1,957	-1,757	-1,625	78	197	-117
Operating Cash Flow to CapEx	55.10%	318.00%	-151.35%	-88.89%	145.45%	17.86%	61.19%	20.83%	256.67%	23.91%	-22.73%
Free Cash Flow to Firm to Interest Expense	-256.35	2.21	0.35	-4.65	-26.63	-19.76	-17.75	-15.93	0.78	2.01	-1.25
Operating Cash Flow to Interest Expense	0.77	3.38	-1.12	-0.41	0.63	0.15	0.41	0.15	1.54	0.22	-0.27
Operating Cash Flow Less CapEx to Interest Expense	-0.63	2.32	-1.86	-0.88	0.20	-0.70	-0.26	-0.56	0.94	-0.71	-1.44
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.35	0.34	0.35	0.35	0.33	0.34	0.35	0.37	0.35	0.36	0.36
Accounts Receivable Turnover	5.51	5.22	5.25	5.33	5.41	5.31	5.28	5.06	5.43	5.14	5.01
Inventory Turnover	2.48	2.53	2.38	2.42	2.36	1.98	1.91	1.99	1.96	1.81	1.83
Fixed Asset Turnover	3.09	2.98	3.02	3.08	3.17	3.08	3.20	3.30	3.39	3.33	3.24
Accounts Payable Turnover	5.09	4.99	4.82	4.49	4.86	3.68	4.16	4.67	4.47	4.11	4.53
Days Sales Outstanding (DSO)	66.27	69.99	69.50	68.48	67.50	68.80	69.12	72.15	67.25	71.04	72.83
Days Inventory Outstanding (DIO)	147.02	144.17	153.17	150.64	154.91	184.06	190.69	183.33	186.58	201.22	198.95
Days Payable Outstanding (DPO)	71.69	73.17	75.70	81.38	75.12	99.14	87.80	78.08	81.59	88.81	80.66
Cash Conversion Cycle (CCC)	141.60	140.99	146.97	137.74	147.29	153.72	172.01	177.40	172.25	183.45	191.12
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	8,936	9,157	9,227	9,267	10,988	11,148	10,988	10,910	10,940	11,012	11,047
Invested Capital Turnover	0.84	0.41	0.41	0.43	0.40	0.41	0.43	0.45	0.43	0.43	0.44
Increase / (Decrease) in Invested Capital	8,936	-68	-19	300	2,052	1,991	1,761	1,643	-48	-136	59
Enterprise Value (EV)	7,576	7,553	8,338	9,339	10,115	10,284	10,399	9,510	11,139	10,899	9,797
Market Capitalization	5,369	5,429	6,094	7,030	5,944	5,986	6,070	5,104	6,788	6,360	5,111
Book Value per Share	$19.23	$20.09	$19.95	$19.87	$19.44	$19.52	$18.97	$18.50	$18.72	$18.38	$18.05
Tangible Book Value per Share	$0.70	$1.34	$1.23	$1.13	($3.91)	($3.75)	($4.00)	($4.19)	($3.91)	($4.38)	($4.63)
Total Capital	9,233	9,537	9,585	9,659	11,348	11,482	11,313	11,212	11,290	11,328	11,262
Total Debt	2,438	2,436	2,533	2,629	4,465	4,562	4,584	4,632	4,629	4,784	4,829
Total Long-Term Debt	2,413	2,411	2,508	2,604	4,435	4,532	4,554	4,602	4,599	4,744	4,789
Net Debt	2,141	2,056	2,175	2,237	4,105	4,228	4,259	4,330	4,279	4,468	4,614
Capital Expenditures (CapEx)	49	50	37	27	33	84	67	72	60	92	110
Debt-free, Cash-free Net Working Capital (DFCFNWC)	388	486	597	623	748	859	831	821	707	774	793
Debt-free Net Working Capital (DFNWC)	685	866	955	1,015	1,108	1,193	1,156	1,123	1,057	1,090	1,008
Net Working Capital (NWC)	660	841	930	990	1,078	1,163	1,126	1,093	1,027	1,050	968
Net Nonoperating Expense (NNE)	-21	36	87	59	108	85	167	166	22	63	153
Net Nonoperating Obligations (NNO)	2,141	2,056	2,175	2,237	4,105	4,228	4,259	4,330	4,279	4,468	4,614
Total Depreciation and Amortization (D&A)	96	96	94	96	101	144	135	135	136	132	133
Debt-free, Cash-free Net Working Capital to Revenue	10.28%	12.90%	15.67%	15.96%	18.85%	20.72%	19.26%	18.26%	15.09%	16.16%	16.42%
Debt-free Net Working Capital to Revenue	18.16%	22.98%	25.07%	26.00%	27.92%	28.77%	26.80%	24.98%	22.57%	22.75%	20.87%
Net Working Capital to Revenue	17.49%	22.32%	24.41%	25.36%	27.16%	28.05%	26.10%	24.32%	21.93%	21.92%	20.05%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.05)	$0.00	($0.26)	($0.09)	($0.24)	($0.15)	($0.48)	($0.43)	$0.01	$0.00	($0.60)
Adjusted Weighted Average Basic Shares Outstanding	350M	350M	350M	350.50M	350.80M	350.50M	351.10M	351.80M	351.90M	351.80M	352.80M
Adjusted Diluted Earnings per Share	($0.05)	$0.00	($0.26)	($0.09)	($0.24)	($0.15)	($0.48)	($0.43)	$0.01	$0.00	($0.60)
Adjusted Weighted Average Diluted Shares Outstanding	350M	350.20M	350M	350.50M	350.80M	350.50M	351.10M	351.80M	353.90M	351.80M	352.80M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	350.00M	350.00M	350.26M	350.70M	350.86M	350.99M	351.48M	351.90M	352.16M	352.47M	353.40M
Normalized Net Operating Profit after Tax (NOPAT)	32	36	-1.40	30	28	34	4.20	18	30	61	-58
Normalized NOPAT Margin	3.42%	3.58%	-0.15%	2.91%	2.78%	2.92%	0.38%	1.50%	2.52%	4.76%	-5.11%
Pre Tax Income Margin	2.02%	-0.20%	-5.91%	-1.84%	-3.48%	-4.86%	-8.19%	-6.25%	-4.85%	-0.78%	-15.83%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	1.49	0.89	-0.16	0.59	0.49	0.39	0.06	0.23	0.38	0.85	-0.95
NOPAT to Interest Expense	-1.04	0.76	-0.03	0.52	0.37	0.35	0.04	0.18	0.30	0.62	-0.62
EBIT Less CapEx to Interest Expense	0.09	-0.17	-0.90	0.12	0.05	-0.45	-0.62	-0.48	-0.22	-0.09	-2.12
NOPAT Less CapEx to Interest Expense	-2.44	-0.30	-0.77	0.05	-0.07	-0.50	-0.63	-0.53	-0.30	-0.32	-1.79
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	15.94%	73.33%	0.00%	0.00%	-4.57%	-3.63%	0.00%	0.00%	-2.82%	-3.28%	0.00%
Augmented Payout Ratio	15.94%	73.33%	0.00%	0.00%	-4.57%	-3.63%	0.00%	0.00%	-2.82%	-3.28%	0.00%

Financials Breakdown Chart

Key Financial Trends

Bausch + Lomb (NYSE: BLCO) has shown several notable financial trends over the past four years through Q1 2025. Below is a summary of key points based on the income statements, cash flow, and balance sheets for this period:

Annual revenue has grown from approximately $3.7 billion in 2022 to over $4.7 billion TTM as of Q1 2025, indicating steady top-line growth.
The company's gross profit margin remains strong around 55%-60%, reflecting good cost controls on product costs.
Operating expenses have been managed relatively consistently, with R&D investment steady around $80-$90 million per quarter, supporting innovation.
Despite some losses on the income statement in recent quarters, the company continues to invest in property, plant, and equipment totaling over $100 million in recent quarters, signaling commitment to capacity expansion or modernization.
Free cash flow, while negative in some recent quarters, is supported by non-cash charges like depreciation and amortization totaling about $130-$140 million quarterly, reflecting asset utilization and amortizable intangibles.
Net income has fluctuated, with losses generally reported in recent quarters except for a few quarters in 2023 where small profits occurred.
Interest expense has increased substantially over the period, reaching around $90-$100 million quarterly, likely due to increased debt levels as seen on the balance sheet.
The company's debt load has risen significantly, with long-term debt rising from about $2.4 billion in Q3 2022 to nearly $4.8 billion by Q1 2025, which increases financial leverage and interest costs.
Cash and equivalents have fluctuated but have remained in the $200-$350 million range, with recent Q1 2025 cash levels at about $202 million.
The company has faced consistent net losses in the last few quarters, including a $211 million loss in Q1 2025, raising concerns about profitability sustainability in the near term.

In summary, Bausch + Lomb has demonstrated growth in revenue and maintained a solid gross margin, though profitability challenges persist, especially with increasing interest expenses due to higher debt. Capital investments remain a positive sign of long-term plans, but investors should monitor operating losses and leverage carefully as these impact earnings stability and credit risk.

10/23/25 10:29 PM ETAI Generated. May Contain Errors.

Frequently Asked Questions About Bausch + Lomb's Financials

When does Bausch + Lomb's financial year end?

According to the most recent income statement we have on file, Bausch + Lomb's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Bausch + Lomb's net income changed over the last 4 years?

Bausch + Lomb's net income appears to be on an upward trend, with a most recent value of -$305 million in 2024, rising from -$17 million in 2020. The previous period was -$248 million in 2023. Find out what analysts predict for Bausch + Lomb in the coming months.

What is Bausch + Lomb's operating income?

Bausch + Lomb's total operating income in 2024 was $162 million, based on the following breakdown:

Total Gross Profit: $2.92 billion
Total Operating Expenses: $2.76 billion

How has Bausch + Lomb's revenue changed over the last 4 years?

Over the last 4 years, Bausch + Lomb's total revenue changed from $3.41 billion in 2020 to $4.79 billion in 2024, a change of 40.4%.

How much debt does Bausch + Lomb have?

Bausch + Lomb's total liabilities were at $6.93 billion at the end of 2024, a 6.2% increase from 2023, and a 387.3% increase since 2021.

How much cash does Bausch + Lomb have?

In the past 3 years, Bausch + Lomb's cash and equivalents has ranged from $174 million in 2021 to $354 million in 2022, and is currently $305 million as of their latest financial filing in 2024.

How has Bausch + Lomb's book value per share changed over the last 4 years?

Over the last 4 years, Bausch + Lomb's book value per share changed from 0.00 in 2020 to 18.38 in 2024, a change of 1,838.1%.

Related Companies

This page (NYSE:BLCO) was last updated on 10/23/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Bausch + Lomb (BLCO) Financials

Financials Breakdown Chart

Key Financial Trends

Frequently Asked Questions About Bausch + Lomb's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Bausch + Lomb (BLCO) Financials

Annual Income Statements for Bausch + Lomb

Quarterly Income Statements for Bausch + Lomb

Annual Cash Flow Statements for Bausch + Lomb

Quarterly Cash Flow Statements for Bausch + Lomb

Annual Balance Sheets for Bausch + Lomb

Quarterly Balance Sheets for Bausch + Lomb

Annual Metrics And Ratios for Bausch + Lomb

Quarterly Metrics And Ratios for Bausch + Lomb

Financials Breakdown Chart

Key Financial Trends

Frequently Asked Questions About Bausch + Lomb's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools